Selamat Datang di
Oddway International

Anggota Gratis
Oddway International
Oddway International
India
Info Perusahaan
Kontak Perusahaan
Nama:Tn. Sharad jINDAL [Penjualan]
E-mail:
Situs Web:
Pesan Instan:
Google Talk:  ODDWAY2010@GMAIL.COM  ODDWAY2010@GMAIL.COM
Nomor Telpon:Nomor telpon Tn. Sharad jINDAL di new delhi
Alamat:daryaganj
Delhi
India
Rata-rata Tinjauan PemakaiTidak ada ulasan untuk perusahaan ini - Menulis tinjauan
Tanggal Bergabung:24 May. 2023
Terakhir Diperbarui:30 Nov. 2011
Sifat Dasar Usaha:Dagang dari kategori Kesehatan & Kecantikan

Ingin menghubungi perusahaan ini?
 
Permintaan Anda akan disimpan di "Surat Bisnis".

Masukan ke Perusahaan Rekanan
Kenalkan ke teman Anda

Penjelasan Ringkas

Oddway International is one of the reliable Merchant, Exporters, Wholesalers and Suppliers of branded and generic Medicines. We have been dealing with Pharmaceutical Products in India since many decades and now present ourselves internationally as an authorized stockist of branded and generic pharmaceutical-products.

Oddway International has successfully met the growing demands of the Pharmaceutical Industry with a wide range of effective formulations and medicines. We distribute a number of OTC ( Over The Counter) drugs and other life-saving drugs which are safe to be consumed. All the medicines that we deal in are cost effective in nature as we buy them directly in bulk quantities. Our substantial growth is mainly attributed to the efficient & quality medicines that we deal in and also our expert sale practices. We directly cater to the needs of large, medium and small enterprises and individuals around the globe. We are a customer oriented company and strongly believe in supplying superior quality medicines at the most economical prices.Our international presence in Singapore as a registered company helps us to cater to our International clients/ customers in a more effcient manner.We also provide International drop-shipping services for retailers and online pharmacies.

Produk / Jasa Utama
Menjual:
  • Buy Geftinat 250mg - gefitinib 250mg - Generic Iressa Tablets
    Geftinat (gefitinib) by Natco is generic version of Iressa. Geftinat is a cancer chemotherapy medication. Geftinat interferes with the growth of cancer cells and slows their growth and spread in the body. Gefitinib is used in the treatment of non-small cell lung cancer. Iressa tablets contain 250 mg of gefitinib and are available as brown film-coated tablets for daily oral administration
  • Soranib 200mg tablets (sorafenib 200mg) Generic Nexavar
    Soranib (sorafenib 200mg) is a cancer (chemotherapeutic) medication. Soranib (sorafenib 200mg) interferes with the growth of cancer cells and slows their growth and spread in the body.
    Soranib (sorafenib 200mg) is used to treat a type of kidney cancer called advanced renal cell carcinoma. It is also used to treat liver cancer.
    Soranib (sorafenib 200mg) may also be used for other purposes not listed in this medication guide.
  • Arimidex- anastrazole 1mg tablets
    This medication is used to treat breast cancer in women who have gone through "the change of life" (menopause). Anastrozole works by lowering estrogen hormone levels to help shrink tumors and slow their growth.
  • Buy Cheap kamagra jelly, kamagra gold tablets, kamagra effervescent tablets, kamagra chewable tablets, super kamagraBuy Cheap kamagra jelly, kamagra gold tablets, kamagra effervescent tablets, kamagra chewable tablets, super kamagra (dropshipping avail
    kamagra jelly,
    kamagra gold tablets 100mg,
    kamagra effervescent tablets,
    kamagra chewable tablets,
    super kamagra
  • Buy Penegra 100mg tablets - generic viagra - sildenafil citrate 100mg tablets at cheapest prices
    Buy Penegra 100mg tablets - generic viagra - sildenafil citrate 100mg tablets at cheapest prices.
  • MTpill (Generic Mifeprex / RU 486) Mifepristone 200mg
    MTPill is indicated for the medical termination of intrauterine pregnancy through 49 days pregnancy. For purposes of this treatment, pregnancy is dated from the first day of the last menstrual period in a presumed 28 days cycle with ovulation occurring at mid-cycle.

    The duration of pregnancy may be determined from menstrual history and by clinical examination. Ultrasonographic scan should be used if the duration of pregnancy is uncertain, or if ectopic pregnancy is suspected.
    Any intrauterine device [“IUD”] should be removed before treatment with MTPill begins. Patients taking MTPill must take 400 mcg of misoprostol two days after taking mifepristone unless a complete abortion has already been confirmed before that time (see DOSAGE AND ADMINISTRATION).
    Pregnancy termination by surgery is recommended in cases when MTPill and misoprostol fail to cause termination of intrauterine pregnancy.

    DOSAGE AND ADMINISTRATION

    Treatment with Mifepristone ( MTPill ) requires concurent administration of misoprostol. Treatment with MTPill and misoprostol for the termination of pregnancy requires three doctor visits by the patient. MTPill may be administered only in a clinic, medical office, or hospital, by or under the supervision of a gynaecologist, able to assess the gestational age of an embryo and to diagnose ectopic pregnancies. The gynaecologist must also be able to provide surgical intervention in cases of incomplete abortion or severe bleeding, or have made plans to provide such care through others, and be able to assure the patient access to medical facilities equipped to provide blood transfusions and resuscitation, if necessary.

    Day One: MTPill Administration
    Three 200 mg tablets (600 mg) of MTPill are taken in a single oral dose.

    Day Three: Misoprostol Administration
    The patient returns to the healthcare provider two days after ingesting MTPill . Unless abortion has occurred and has been confirmed by clinical examination or ultrasonographic scan, the patient takes two 200-mcg tablets (400 mcg) of misoprostol orally.
    During the period immediately following the administration of Misoprostol, the patient may need medication for cramps or gastrointestinal symptoms. The patient should be given instructions on what to do if significant discomfort, excessive bleeding or other adverse reactions occur and should be given a phone number to call if she has questions following the administration of the misoprostol.

    Day 14: Post-Treatment Examination
    Patients will return for a follow-up visit approximately 14 days after the administration of MTPill . This visit is very important to confirm by clinical examination or ultrasonographic scan that a complete termination of pregnancy has occurred.
    Patients who have an ongoing pregnancy at this visit have a risk of foetal malformation resulting from the treatment. Surgical termination is recommended to manage medical abortion treatment failures.

    CONTRAINDICATIONS

    Administration of MTPill and misoprostol for the termination of pregnancy (the “treatment procedure”) is contraindicated in patients with any one of the following conditions:

    * Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass (the treatment procedure will not be effective to terminate an ectopic pregnancy)
    * IUD in place
    * Chronic adrenal failure
    * History of allergy to mifepristone, misoprostol or other prostaglandin
    * Haemorrhagic disorders or concurrent anticoagulant therapy
    * Inherited porphyria
    Because it is important to have access to appropriate medical care if an emergency develops, the treatment procedure is contraindicated if a patient does not have adequate access to medical facilities equipped to provide emergency treatment of incomplete abortion, blood transfusions, and emergency resuscitation during the period from the first visit until discharged by the administering physician.



  • Saya kenal dengan perusahaan ini dan ingin memberikan tinjauan.


Anda mendapat [3] permintaan baru.
Ke Menu Anggota

Depan - Penawaran Dagang - Daftar Produk - Daftar Permintaan - Daftar Kerjasama - Daftar Perusahaan
© 2024 Indotrade.com. Hak Cipta Dilindungi Undang-undang.